RANDOMISED CONTROLLED CLINICAL TRIAL OF NAGKESHAR CHURNA WITH TAKRA IN THE MANAGEMENT OF SHWETPRADAR W.S.R TO BACTERIAL VAGINOSIS

RANDOMIZED CONTROLLED CLINICAL TRIAL OF NAGKESHAR CHURNA WITH TAKRA IN THE MANAGEMENT OF SHWETPRADAR WITH SPECIAL REFERENCE TO BACTERIAL VAGINOSIS - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067092

Enrollment

100

Registered

2024-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N760- Acute vaginitis Health Condition 2: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Indoor and outdoor patient having yonigata shwetstrava. Married patient. Patient having cervicitis are icluded

Exclusion criteria

Exclusion criteria: Patient age less than 18 and more than 45 years Pregnant females Neoplasia including malignancies Immune compromised patients Patient with other systemic disorders like vaginal tuberculosis, Diabetes Mellitus,Hypertension Patient using intrauterine Contraceptive Devices Patient with sexually Transmitted diseases

Design outcomes

Primary

Measure	Time frame
To study the role of nagkeshar churn with takra in the management of shwetpradarTimepoint: 7 days	—

Secondary

Measure	Time frame
To study details about shwetpradar To study properties of Nagkeshar & takraTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr.Rhuta Naimish Saraf

Sidhhakala Ayurved Mahavidyalay sangamner

rhutasaraf@gmail.com9890624712

Outcome results